Influx Allograft Family

About ISTO Biologics

ISTO Biologics is a well-established, privately held player in the orthobiologics market, offering a diversified portfolio of commercial products for bone regeneration and soft tissue healing. The company has grown through strategic mergers and acquisitions, integrating key technologies like the Magellan autologous system and the Influx allograft line to build a comprehensive suite of solutions. Its business model is commercial and revenue-generating, selling directly to surgeons, hospitals, and distributors in the musculoskeletal space. ISTO's strategy focuses on providing customizable, procedure-specific biologics to improve surgical outcomes.

Therapeutic Areas

Other Bone grafting for orthopedic/spine procedures Drugs